1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. North Carolina >
  6. GSK Acquires Stiefel Laboratories

M&A Deal Summary

GSK Acquires Stiefel Laboratories

On April 20, 2009, GSK acquired life science company Stiefel Laboratories from The Blackstone Group for 2.9B USD

Acquisition Highlights
  • This is GSK’s 12th transaction in the Life Science sector.
  • This is GSK’s 5th largest (disclosed) transaction.
  • This is GSK’s 11th transaction in the United States.
  • This is GSK’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2009-04-20
Target Stiefel Laboratories
Sector Life Science
Buyer(s) GSK
Sellers(s) The Blackstone Group
Deal Type Add-on Acquisition
Deal Value 2.9B USD

Target

Stiefel Laboratories

Research Triangle Park, North Carolina, United States
Stiefel Laboratories, Inc. is enthusiastically committed to advancing dermatology and skin science around the world. The company’s deeply-rooted dedication and drive for innovation along with its sole focus on dermatology has led Stiefel to become the largest independent dermatology company in the world. In addition to more than 30 wholly-owned subsidiaries, six manufacturing plants and a global research and development network, Stiefel’s most valuable asset is its global network of nearly 3,500 driven associates.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

GSK

Brentford, United Kingdom
Category Company
Founded 1715
Sector Life Science
Employees68,629
Revenue 31.4B GBP (2024)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.

DEAL STATS #
Overall 14 of 35
Sector: Life Science M&A 12 of 28
Type: Add-on Acquisition M&A Deals 10 of 25
State: North Carolina M&A 1 of 1
Country: United States M&A 11 of 21
Year: 2009 M&A 2 of 5
Size (of disclosed) 5 of 31
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-23 UCB - Pharmaceutical Brands

Belgium

UCB - Pharmaceutical Brands include Keppra for the treatment of epilepsy and Xyzal and Zyrtec for the treatment of allergic rhinitis. The acquired products will be sold in multiple territories. Asia Pacific territories include Malaysia, Taiwan, Thailand and Vietnam. Middle Eastern territories include Egypt, Pakistan, Saudi Arabia and United Arab Emirates. African territories include South Africa. Latina territories include Argentina and Chile. Territories excluded are China, South Korea, India, Australia, Mexico, Brazil and Malta.

Buy €515M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-05-06 GlaxoSmithKline - Wellbutrin XL

United States

GlaxoSmithKline plc - Wellbutrin XL which is indicated for the treatment of major depressive disorder and seasonal affective disorder, was developed and is manufactured by Biovail and has been distributed by GSK in the United States since September 2003.

Sell $510M

Seller(S) 1

SELLER

The Blackstone Group

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1987
PE ASSETS 394.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

The Blackstone Group is a global alternative investment management firm. The Firm's investment activities span real estate, secondary investments, hedge funds, credit, infrastructure, and private equity. Blackstone's private equity group targets opportunities globally including buyout acquisitions of established companies, development projects, growth equity financings, and industry consolidations. Sectors of interest include automotive, healthcare, chemicals, industrial, commercial property, lodging, communications, media/publishing, consumer & retail, packaging, consumer products, pharmaceuticals, energy, technology, entertainment, telecommunications, financial services, theme parks, food & beverage, and transportation. Blackstone's private equity real estate group looks for opportunities across North/South America, Asia, Australia/New Zealand, and Europe. The real estate group will consider both equity and debt investments. Areas of interest include healthcare, hotel, industrial, office, residential, and retail. The Blackstone Group was formed in 1987 and is based in New York, New York.

DEAL STATS #
Overall 43 of 193
Sector: Life Science M&A 2 of 5
Type: Add-on Acquisition M&A Deals 18 of 74
State: North Carolina M&A 2 of 5
Country: United States M&A 29 of 117
Year: 2009 M&A 1 of 7
Size (of disclosed) 18 of 60
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-12-01 CMS Info Systems

Mumbai, India

CMS Info Systems provides IT & outsourced business services across India. The company offers a wide bouquet of services across the value chain, focusing on retail banks, insurance, telecom, retail, PSU and Government segments. CMS Info Systems was founded in 2008 and is based in Mumbai, Maharashtra.

Buy $40M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-05-20 BankUnited

Miami Lakes, Florida, United States

BankUnited is a bank holding company providing various commercial and consumer banking services. BankUnited was founded in 2009 and is based in Miami Lakes, Florida.

Buy $900M
Mergr

Solution for

Product

Company

Legal